Correlation Between Replimune and Ikena Oncology
Can any of the company-specific risk be diversified away by investing in both Replimune and Ikena Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Replimune and Ikena Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Replimune Group and Ikena Oncology, you can compare the effects of market volatilities on Replimune and Ikena Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Replimune with a short position of Ikena Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Replimune and Ikena Oncology.
Diversification Opportunities for Replimune and Ikena Oncology
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between Replimune and Ikena is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Replimune Group and Ikena Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ikena Oncology and Replimune is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Replimune Group are associated (or correlated) with Ikena Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ikena Oncology has no effect on the direction of Replimune i.e., Replimune and Ikena Oncology go up and down completely randomly.
Pair Corralation between Replimune and Ikena Oncology
Given the investment horizon of 90 days Replimune Group is expected to generate 2.97 times more return on investment than Ikena Oncology. However, Replimune is 2.97 times more volatile than Ikena Oncology. It trades about 0.12 of its potential returns per unit of risk. Ikena Oncology is currently generating about -0.27 per unit of risk. If you would invest 1,256 in Replimune Group on November 3, 2024 and sell it today you would earn a total of 142.00 from holding Replimune Group or generate 11.31% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Replimune Group vs. Ikena Oncology
Performance |
| Timeline |
| Replimune Group |
| Ikena Oncology |
Replimune and Ikena Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Replimune and Ikena Oncology
The main advantage of trading using opposite Replimune and Ikena Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Replimune position performs unexpectedly, Ikena Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ikena Oncology will offset losses from the drop in Ikena Oncology's long position.| Replimune vs. Nuvalent | Replimune vs. Ventyx Biosciences | Replimune vs. Ascendis Pharma AS | Replimune vs. United Therapeutics |
| Ikena Oncology vs. Edgewise Therapeutics | Ikena Oncology vs. Design Therapeutics | Ikena Oncology vs. Xilio Development | Ikena Oncology vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |